New York, July 19, 2018: The Global Point-of-Care Testing (POCT) Market is expected to exceed more than US$ 35.2 Billion by 2024 at a CAGR of 9% in the given forecast period.

The scope of the report includes a detailed study of Global Point-of-Care Testing (POCT) Market with the reasons given for variations in the growth of the industry in certain regions.

POCT is considered together of the foremost reasonable technologies of world medical specialty market, and development in POCT technologies over amount of your time has been meted out through innovations in smart and transportable bio-sensor, computing, and knowledge and communication technologies. According to market consultants the factors helping the expansion of POC medical specialty market are many government initiatives have power-assisted within the development of innovative outpatient care models, to reduce hospital stays and quickly increasing demand for home health care globally.

Global Point-of-Care Testing (POCT) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Global Point-of-Care Testing (POCT) Market is Segmented on the lines of End-User Type, Product Type and Regional Analysis. By End-User Type this market is segmented on the basis of Clinics Sector, Home Sector, Laboratories Sector, Assisted living healthcare facilities Sector and Hospitals Sector.

By Product Type this market is segmented on the basis of Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing and Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.